Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP), is a rare (globally, it’s estimated
8,000-10,000 people) and fatal neurodegenerative disease primarily caused by a genetic mutation
of the TTR gene. Diagnosis tends to be delayed because TTR-FAP can be mistaken for other
more common neuropathies. Our goal was to humanize the disease, put a face to it for the consumer.
